Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Stichting European Myeloma Network
Pieter Sonneveld; Meletios A Dimopoulos; Mario Boccadoro; Hang Quach; P Joy Ho; Meral Beksac; Cyrille Hulin; Elisabetta Antonioli; Xavier Leleu; Silvia Mangiacavalli; Aurore Perrot; Michele Cavo; Angelo Belotti; Annemiek Broijl; Francesca Gay; Roberto Mina; Inger S Nijhof; Niels W C J van de Donk; Eirini Katodritou; Fredrik Schjesvold; Anna Sureda Balari; Laura Rosiñol; Michel Delforge; Wilfried Roeloffzen; Tobias Silzle; Annette Vangsted; Hermann Einsele; Andrew Spencer; Roman Hajek; Artur Jurczyszyn; Sarah Lonergan; Tahamtan Ahmadi; Yanfang Liu; Jianping Wang; Diego Vieyra; Emilie M J van Brummelen; Veronique Vanquickelberghe; Anna Sitthi-Amorn; Carla J de Boer; Robin Carson; Paula Rodriguez-Otero; Joan Bladé; Philippe Moreau; PERSEUS Trial Investigators